![](/img/cover-not-exists.png)
Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
John W. Eikelboom, Martin O'Donnell, Salim Yusuf, Rafael Diaz, Greg Flaker, Robert Hart, Stefan Hohnloser, Campbell Joyner, Jack Lawrence, Prem Pais, Janice Pogue, David Synhorst, Stuart J. ConnollyVolume:
159
Year:
2010
Language:
english
Pages:
3531
DOI:
10.1016/j.ahj.2009.08.026
File:
PDF, 208 KB
english, 2010